Suitability of saphenous vein graft lesions for the use of distal embolic protection devices.
The use of distal embolic protection devices (EPD) in saphenous vein graft percutaneous interventions (SVG-PCI) has been associated with a decrease in adverse events. Currently, there are limited data regarding the percentage of SVG lesions that are suitable for EPD deployment. We retrospectively reviewed 131 SVG-PCI procedures occurring over 18 months for suitability for EPD deployment, utilizing previously published suitability criteria. We found that 49% of cases were suitable for EPD use, which is similar to results from other studies. Given the data supporting the use of EPD use in SVG-PCI, we feel that these findings should motivate interventional operators to establish benchmark standards for employing EPDs to improve the care of patients undergoing SVG-PCI.
Mehta
Sameer K
SK
Mid-America Heart Institute, St. Luke's Hospital, Kansas City, Missouri 64111, USA.
Stolker
Joshua M
JM
Frutkin
Andrew D
AD
Marso
Steven P
SP
D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D003327:Coronary Disease / Q000628:therapy; D003430:Cross-Sectional Studies; D004617:Embolism / Q000517:prevention & control*; D005260:Female; D006083:Graft Occlusion, Vascular / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012042:Registries; D012189:Retrospective Studies; D012501:Saphenous Vein; D016896:Treatment Outcome